Hikaru Sasaki

Sugano, 2728513, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 105 publications

Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.

Annexin A2 associated with bevacizumab resistance and infiltrative escape in glioblastoma.

Journal: Journal of neuro-oncology
Published: June 17, 2026

Glioma Segmentation on Multicenter 2D-Based Magnetic Resonance Imaging Using Low-Rank Adaptation Tuning of a Foundation Model: An External Test Evaluation.

Glioma Segmentation on Multicenter 2D-Based Magnetic Resonance Imaging Using Low-Rank Adaptation Tuning of a Foundation Model: An External Test Evaluation.

Journal: Journal of imaging informatics in medicine
Published: May 06, 2026

Polar Wurtzite NbAlN: A Transition-Metal Nitride Alloy for Polarization-Engineered GaN Heterostructures.

Polar Wurtzite NbAlN: A Transition-Metal Nitride Alloy for Polarization-Engineered GaN Heterostructures.

Journal: Advanced materials (Deerfield Beach, Fla.)
Published: January 14, 2026

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching.

Validation of Preoperative Neoadjuvant Bevacizumab Therapy for Newly Diagnosed Glioblastoma via Comparative Analyses with Propensity Score Matching.

Journal: Cancers
Published: January 13, 2026

Surgical Strategy for Superior Cerebellar Peduncle Lesions: Utility of the Subtemporal Transtentorial Approach.

Surgical Strategy for Superior Cerebellar Peduncle Lesions: Utility of the Subtemporal Transtentorial Approach.

Journal: World neurosurgery
Published: August 21, 2025

The Empty Sylvian Fissure Sign: A Novel Non-contrast CT Finding in Moyamoya Disease.

The Empty Sylvian Fissure Sign: A Novel Non-contrast CT Finding in Moyamoya Disease.

Journal: Cureus
Published: January 13, 2025

Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant.

Integrated analysis of MYC expression, 8q24.21 copy number, and recurrence patterns in astrocytoma, IDH-mutant.

Journal: Brain tumor pathology
Published: December 19, 2024

Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.

Response to correspondence on an exploratory prospective phase II study of preoperative neoadjuvant bevacizumab and temozolomide for newly diagnosed glioblastoma.

Journal: Journal of neuro-oncology
Published: August 03, 2024

Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.

Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.

Journal: Scientific reports
Published: May 19, 2024

Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.

Correction: Status of alternative angiogenic pathways in glioblastoma resected under and after bevacizumab treatment.

Journal: Brain tumor pathology
Published: May 07, 2024

Development of microsurgical forceps equipped with haptic technology for in situ differentiation of brain tumors during microsurgery.

Development of microsurgical forceps equipped with haptic technology for in situ differentiation of brain tumors during microsurgery.

Journal: Scientific reports
Published: April 01, 2024

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.

Oligodendroglioma, IDH-mutant and 1p/19q-codeleted-prognostic factors, standard of care and chemotherapy, and future perspectives with neoadjuvant strategy.

Journal: Brain tumor pathology
Published: January 10, 2024
Showing 1-12 of 105

Last Updated: 09/26/2026